Medicine and Dentistry
Patient Referral
100%
Chronic Obstructive Pulmonary Disease
78%
Randomized Controlled Trial
62%
Lower Respiratory Tract Infection
62%
Sputum
62%
Chronic Kidney Disease
62%
Inflammatory Bowel Disease
62%
Disease
53%
Diagnosis
47%
Inflammatory Disorder
44%
Treatment Response
44%
COVID-19
41%
Emergency Department
40%
Cross Sectional Study
39%
C Reactive Protein
36%
General Practitioner
36%
Malignant Neoplasm
36%
Side Effect
36%
Pathogen
35%
Biological Marker
34%
Medicine
33%
Adverse Event
32%
Prospective Cohort Study
31%
Angina pectoris
31%
Procalcitonin
31%
Coronary Artery Disease
31%
Group A Streptococcal Infection
31%
Acute Gastroenteritis
31%
Diagnostic Accuracy
31%
Inflammatory Bowel Disease
31%
MHealth
31%
Urokinase Receptor
31%
Alpha Tocotrienol
31%
Adverse Outcome
31%
microRNA
31%
Nephrologist
31%
Streptococcus pyogenes
31%
Retrospective Cohort Study
31%
Nephropathy
31%
Medical History
31%
Gestational Diabetes
31%
Randomized Clinical Trial
31%
Congenital Long-QT Syndrome
31%
Surgery
31%
Thorax Pain
31%
Diet and Cancer
31%
Atrial Fibrillation
31%
Urinary Tract Infection
31%
Gram Staining
31%
Metabolic Syndrome
31%
Hypercholesterolemia
31%
Circulating Tumor DNA
31%
Phase II Trials
31%
Breast Cancer
31%
Neoadjuvant Therapy
31%
Telemedicine
31%
Connective Tissue
31%
Cardiovascular Disease
28%
Robot-Assisted Surgery
26%
microRNA 29b
23%
Diabetes Mellitus
23%
Outpatient
23%
Extracellular Matrix
23%
Proportional Hazards Model
22%
Arm
21%
Whole Genome Sequencing
20%
Familial Hypercholesterolemia
20%
Prevalence
20%
Health Care
20%
Symptomatic Treatment
18%
Antibiotic Therapy
15%
Nephrology
15%
Laparoscopic Surgery
15%
Patient with Diabetes
15%
Rhythm
15%
Osteoporosis
15%
Methylation
15%
Breast Tissue
15%
Cohort Analysis
15%
Ulcerative Colitis
15%
Hazard Ratio
14%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Pediatrics
13%
Crohn's Disease
13%
Population Dynamics
13%
Diabetes
13%
Nutrition Assessment
12%
Multiple Sclerosis
11%
All Cause Mortality
11%
Streptococcus Group A
10%
Meningitis
10%
Statin
10%
Low Density Lipoprotein Cholesterol
10%
Creatine Kinase
10%
Colorectal Carcinoma
10%
Bloodstream Infection
10%
Post-Hoc Analysis
9%
Patient Registry
9%
Patient Experience
8%
Elderly Patient
8%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
92%
Inflammatory Disease
76%
Cohort Study
66%
Kidney Disease
62%
Chronic Kidney Failure
62%
Colorectal Carcinoma
62%
Inflammatory Bowel Disease
62%
Biological Marker
62%
Prevalence
45%
Bloodstream Infection
41%
All Cause Mortality
39%
Side Effect
36%
Acute Heart Infarction
31%
microRNA
31%
Streptococcus pyogenes
31%
Urokinase Receptor
31%
Group A Streptococcal Infection
31%
Long QT Syndrome
31%
Urinary Tract Infection
31%
Acute Gastroenteritis
31%
Pregnancy Diabetes Mellitus
31%
Atrial Fibrillation
31%
Aspergillus fumigatus
31%
Group Trial
31%
Prospective Cohort Study
31%
Alpha Tocotrienol
31%
Procalcitonin
31%
Breast Cancer
31%
C Reactive Protein
31%
Metabolic Syndrome X
31%
Circulating Tumor DNA
31%
Randomized Clinical Trial
31%
Phase II Trials
31%
Hypercholesterolemia
31%
Anaerobic Bacterium
31%
Pyrrole
31%
Biological Product
31%
Diabetes Mellitus
25%
Familial Hypercholesterolemia
20%
Ulcerative Colitis
20%
Malignant Neoplasm
18%
Cardiovascular Disease
16%
Crohn's Disease
16%
SARS Coronavirus
13%
Streptococcus Group A
10%
Meningitis
10%
Creatine Kinase
10%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
10%
Low Density Lipoprotein Cholesterol
10%
Psoriatic Arthritis
9%
Psoriasis
9%
Inflammatory Arthritis
9%
Streptococcus
8%
Intestine Flora
8%
Heart Infarction
8%
Alpha Tocopherol
7%
Adverse Event
7%
Chemotherapy
7%
Circulating microRNA
7%
Cerebrovascular Accident
7%
Spondylarthritis
7%
Diseases
7%
Cross-Sectional Study
7%
Cancer Mortality
6%
Dyslipidemia
5%
Heart Ventricle Tachycardia
5%
Faintness
5%
Sudden Cardiac Death
5%
Nursing and Health Professions
Palliative Therapy
96%
Patient Referral
68%
Cohort Analysis
67%
Telemedicine
62%
Obstructive Lung Disease
62%
Ward
62%
Health Care Personnel
62%
Patient Preference
37%
Confidence Interval
36%
Quality Adjusted Life Year
31%
Cost Utility Analysis
31%
Prospective Cohort Study
31%
Systolic Blood Pressure
31%
General Practitioner
31%
Pressure Injury
31%
Lower Respiratory Tract Infection
31%
Coronary Artery Disease
31%
Palliative Care Education
31%
Adverse Outcome
31%
Acute Gastroenteritis
31%
Spinal Cord Injury
31%
Pandemic
31%
Blood Pressure
31%
Thorax Pain
31%
Inflammatory Bowel Disease
31%
Biological Product
31%
Treatment Response
31%
Inflammatory Disease
31%
Biological Marker
31%
Palliative Oncology
31%
Outpatient
31%
Quality of Life
28%
Care Group
25%
Student T Test
21%
Prevalence
21%
Adverse Event
15%
Social Network
15%
Pilot Study
15%
Biological Therapy
15%
Shared Decision-Making
15%
Diseases
15%
Family Nursing
15%
Multiple Chronic Conditions
15%
Severe Acute Respiratory Syndrome
13%
Incremental Cost-Effectiveness Ratio
12%
Outpatient Department
12%
Emergency Ward
12%
Patient Care
10%
Revascularization
10%
Crohn's Disease
10%
Ulcerative Colitis
10%
Thematic Analysis
9%
Elderly Patient
8%
Diagnosis
7%
Odds Ratio
7%
Intention to Treat Analysis
7%
Infection Control
7%
Hazard Ratio
7%
Proportional Hazards Model
7%
Psoriatic Arthritis
7%
Confounding Factor
7%
Clinical Assessment
7%
Inflammatory Arthritis
7%
Spondylarthritis
7%
Treatment Outcome
7%
Psoriasis
7%
Practice Guideline
6%
Video Consultation
6%
Outpatient Care
6%
Hospital Readmission
5%
Mortality Rate
5%
All Cause Mortality
5%